FE75C
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for FE75C, covering 2008-01-21 to 2014-05-14. Get the full timeline:
Most recent: Clinical Trial Update: Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer [Phase 3]